Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...